PFIZER REPORTS FIRST-QUARTER 2020 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Pfizer (PFE) Tops Q1 EPS by 7c, Reaffirms FY20 EPS Guidance
April 28, 2020 6:47 AM EDTPfizer (NYSE: PFE) reported Q1 EPS of $0.80, $0.07 better than the analyst estimate of $0.73. Revenue for the quarter came in at $12 billion versus the consensus estimate of $11.89 billion.
GUIDANCE:
Pfizer sees FY2020 EPS of $2.82-$2.92, versus the consensus of $2.86. Pfizer sees FY2020 revenue of $48.5-50.5 billion, versus the consensus of $49.33 billion.
Todays guidance update reflects managements current expectations for operational performance, foreign exchange rates as well as various COVID-19-related uncertainties, primarily those related to the severity, duration and global macroeconomic impact of the pandemic. Key guidance assumptions related to... More
